How much did Il Dong Pharmaceutical Co achieve in EBIT for the current year?
In the current year, Il Dong Pharmaceutical Co has achieved an EBIT of 28.74 B KRW.
In 2024, Il Dong Pharmaceutical Co's EBIT was 28.74 B KRW, a -153.27% increase from the -53.94 B KRW EBIT recorded in the previous year.
YEAR | EBIT (undefined KRW) |
---|---|
2024e | 28.74 |
2023 | -53.94 |
2022 | -73.48 |
2021 | -55.54 |
2020 | 6.63 |
2019 | -1.37 |
2018 | 28.34 |
2017 | 25.36 |
2016 | 14.79 |
Il Dong Pharmaceutical Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
A yearly comparison of Il Dong Pharmaceutical Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Il Dong Pharmaceutical Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Fluctuations in Il Dong Pharmaceutical Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
In the current year, Il Dong Pharmaceutical Co has achieved an EBIT of 28.74 B KRW.
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Il Dong Pharmaceutical Co.
The EBIT of Il Dong Pharmaceutical Co has increased by -153.269% decreased compared to the previous year.
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
The EBIT of Il Dong Pharmaceutical Co is listed in the income statement.
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
Over the past 12 months, Il Dong Pharmaceutical Co paid a dividend of 362.81 KRW . This corresponds to a dividend yield of about 2.35 %. For the coming 12 months, Il Dong Pharmaceutical Co is expected to pay a dividend of 0 KRW.
The current dividend yield of Il Dong Pharmaceutical Co is 2.35 %.
Il Dong Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of .
Il Dong Pharmaceutical Co paid dividends every year for the past 1 years.
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
Il Dong Pharmaceutical Co is assigned to the 'Health' sector.
To receive the latest dividend of Il Dong Pharmaceutical Co from 4/11/2019 amounting to 380.952 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2018.
The last dividend was paid out on 4/11/2019.
In the year 2023, Il Dong Pharmaceutical Co distributed 0 KRW as dividends.
The dividends of Il Dong Pharmaceutical Co are distributed in KRW.
Our stock analysis for Il Dong Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Il Dong Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.